REPLICEL LIFE SCIENCES INC. | CIK:0001205059 | 3

  • Filed: 5/11/2018
  • Entity registrant name: REPLICEL LIFE SCIENCES INC. (CIK: 0001205059)
  • Generator: Compliance Xpressware
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1205059/000106299318002112/0001062993-18-002112-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1205059/000106299318002112/repcf-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001205059
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfIncomeTaxExplanatory

    10.

    Income Taxes


      a)

    Income tax recognized in profit or loss:


          2017     2016     2015  
                         
      Canadian current tax expense $   -   $   -   $   -  
      Foreign current tax expense   -     -     -  
      Deferred tax expense   -     -     -  
      Total   -     -     -  

      b)

    Reconciliation of accounting and taxable income, for the years ended December 31 are as follows:


          2017     2016     2015  
                         
      Net income (loss) for the year before taxes $   (6,014,330 ) $ (4,271,294 ) $ (5,044,012 )
      Combined federal and provincial income tax rate   26.00%     26.00%     26.00%  
      Expected income tax expense (recovery)   (1,564,000 )   (1,111,000 )   (1,311,000 )
         Increase (decrease) resulting from                  
         SR&ED credit claims   (3,000 )   78,000     (210,000 )
         Stock-based compensation   31,000     189,000     34,000  
         Non-deductible (Non-Taxable) items   (79,000 )   (55,000 )   24,000  
         Tax adjustment from rate change and other   (262,000 )   -     -  
         Change in unrecognized deferred tax assets   1,877,000     899,000     1,501,000  
      Income tax expense $   -   $   -   $   -  

     

      c)

    The components of the deferred tax asset (liability) balances for the years ended December 31, are as follows:


          2017     2016     2015  
                         
      Deferred tax assets                  
      Non-capital losses $ 6,401,000   $ 4,703,000   $ 3,741,000  
      Equipment and other   223,000     78,000     76,000  
      Temporary differences relating to intellectual property costs   -     136,000     136,000  
      Foreign tax credit   412,000     412,000     412,000  
      Un-deducted SR&ED expenditure pool   412,000     320,000     320,000  
      Investment tax credit   196,000     161,000     239,000  
      Share issuance costs   156,000     113,000     100,000  
      Unrecognized deferred tax assets   (7,800,000 )   (5,923,000 )   (5,024,000 )
        $   -   $   -   $   -  

    Deferred tax assets in respect of losses and other temporary differences are recognized when it is more likely than not, that they will be recovered against profits in future periods. No deferred tax asset has been recognized as this criteria has not been met.

    At December 31, 2017, the Company has Canadian non capital losses totalling approximately $23,714,000 that expire beginning in 2026:

    Year of Expiry   Amount  
    2026 $ 6,000  
    2027   16,000  
    2028   533,000  
    2029   863,000  
    2031   2,080,000  
    2032   2,290,000  
    2033   39,000  
    2034   3,908,000  
    2035   4,356,000  
    2036   3,583,000  
    2037   6,040,000  
      $ 23,714,000